PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7533611-0	1995	Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.	lavendustin A	83-96	vascular endothelial growth factor A	Rattus norvegicus	15-19	
7533611-16	1995	This VEGF/bFGF neovascular response was also blocked by daily co-administration of lavendustin A (10 jig),suramin (3 mg) or a monoclonal anti-bFGF antibody (DG2, I jig), but not lavendustin B (10 g).6 These results suggest that selective inhibition of PTK could have therapeutic potential in angiogenic diseases where VEGF plays a dominant role.	lavendustin A	83-96	vascular endothelial growth factor A	Rattus norvegicus	5-9	
7533611-16	1995	This VEGF/bFGF neovascular response was also blocked by daily co-administration of lavendustin A (10 jig),suramin (3 mg) or a monoclonal anti-bFGF antibody (DG2, I jig), but not lavendustin B (10 g).6 These results suggest that selective inhibition of PTK could have therapeutic potential in angiogenic diseases where VEGF plays a dominant role.	lavendustin A	83-96	vascular endothelial growth factor A	Rattus norvegicus	318-322